{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:52:13Z","timestamp":1761519133491,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.4158\/ep14498.or","type":"journal-article","created":{"date-parts":[[2015,8,26]],"date-time":"2015-08-26T17:16:36Z","timestamp":1440609396000},"page":"1323-1332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Fasting Versus Postprandial Hyperglycemia as a Treatment Target to Lower Elevated Hemoglobin A1C"],"prefix":"10.1016","volume":"21","author":[{"given":"Charles","family":"Shaefer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Reid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Vlajnic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andres","family":"DiGenio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP14498.OR_bb0010","unstructured":"International Diabetes Federation (IDF). IDF Diabetes Atlas, 6th edition, 2014 update. Available at: http:\/\/www.idf.org\/sites\/default\/files\/Atlas-poster-2014_EN.pdf. Accessed October 13, 2015."},{"key":"10.4158\/EP14498.OR_bb0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2337\/diacare.27.1.17","article-title":"Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report","volume":"27","author":"Koro","year":"2004","journal-title":"Diabetes Care"},{"key":"10.4158\/EP14498.OR_bb0020","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.annepidem.2007.10.007","article-title":"Prevalence, treatment, and control of diagnosed diabetes in the U.S. National Health and Nutrition Examination Survey 1999\u20132004","volume":"18","author":"Ong","year":"2008","journal-title":"Ann Epidemiol"},{"key":"10.4158\/EP14498.OR_bb0025","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.2337\/dc12-2258","article-title":"The prevalence of meeting A1c, blood pressure, and LDL goals among people with diabetes, 1988\u20132010","volume":"36","author":"Stark Casagrande","year":"2013","journal-title":"Diabetes Care"},{"key":"10.4158\/EP14498.OR_bb0030","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2337\/dc14-2441","article-title":"Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"38","author":"Inzucchi","year":"2015","journal-title":"Diabetes Care"},{"key":"10.4158\/EP14498.OR_bb0035","doi-asserted-by":"crossref","first-page":"327","DOI":"10.4158\/EP13176.CSUPPL","article-title":"AACE comprehensive diabetes management algorithm 2013","volume":"19","author":"Garber","year":"2013","journal-title":"Endocr Pract"},{"key":"10.4158\/EP14498.OR_bb0040","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2337\/diacare.15.7.815","article-title":"Onset of NIDDM occurs at least 4\u20137 yr before clinical diagnosis","volume":"15","author":"Harris","year":"1992","journal-title":"Diabetes Care"},{"key":"10.4158\/EP14498.OR_bb0045","doi-asserted-by":"crossref","first-page":"992","DOI":"10.2337\/diacare.13.9.992","article-title":"Natural history of beta-cell dysfunction in NIDDM","volume":"13","author":"Leahy","year":"1990","journal-title":"Diabetes Care"},{"key":"10.4158\/EP14498.OR_bb0050","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2337\/dc06-1612","article-title":"The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes","volume":"30","author":"Monnier","year":"2007","journal-title":"Diabetes Care"},{"key":"10.4158\/EP14498.OR_bb0055","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1001\/archinte.164.15.1627","article-title":"Diagnostic and therapeutic implications of relationships between fasting, 2-hour postchallenge plasma glucose and hemoglobin a1c values","volume":"164","author":"Woerle","year":"2004","journal-title":"Arch Intern Med"},{"issue":"suppl 1","key":"10.4158\/EP14498.OR_bb0060","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.2337\/dc13-S067","article-title":"Diagnosis and classification of diabetes mellitus","volume":"36","author":"American Diabetes Association","year":"2013","journal-title":"Diabetes Care"},{"key":"10.4158\/EP14498.OR_bb0065","first-page":"152","article-title":"Insulin therapy in type 2 diabetes mellitus: a practical approach for primary care physicians and other health care professionals","volume":"113","author":"LaSalle","year":"2013","journal-title":"J Am Osteopath Assoc"},{"key":"10.4158\/EP14498.OR_bb0070","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2337\/diacare.26.3.881","article-title":"Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c)","volume":"26","author":"Monnier","year":"2003","journal-title":"Diabetes Care"},{"key":"10.4158\/EP14498.OR_bb0075","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.2337\/dc11-0632","article-title":"Contributions of basal and postprandial hyperglycemia over a wide range of A1c levels before and after treatment intensification in type 2 diabetes","volume":"34","author":"Riddle","year":"2011","journal-title":"Diabetes Care"},{"issue":"suppl 1","key":"10.4158\/EP14498.OR_bb0080","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.2337\/dc15-S004","article-title":"Standards of medical care in diabetes\u20132015","volume":"38","author":"American Diabetes Association","year":"2015","journal-title":"Diabetes Care"},{"key":"10.4158\/EP14498.OR_bb0085","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.diabres.2006.11.011","article-title":"Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes. Importance of postprandial glycemia to achieve target HbA1c levels","volume":"77","author":"Woerle","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"key":"10.4158\/EP14498.OR_bb0090","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.2337\/diacare.26.11.3080","article-title":"The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients","volume":"26","author":"Riddle","year":"2003","journal-title":"Diabetes Care"},{"key":"10.4158\/EP14498.OR_bb0095","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2337\/diacare.28.2.419","article-title":"Good glycemic control with flexibility in timing of basal insulin supply: a 24-week comparison of insulin glargine given once daily in the morning or at bedtime in combination with morning glimepiride","volume":"28","author":"Standl","year":"2005","journal-title":"Diabetes Care"},{"key":"10.4158\/EP14498.OR_bb0100","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2337\/diacare.28.2.254","article-title":"Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes","volume":"28","author":"Janka","year":"2005","journal-title":"Diabetes Care"},{"key":"10.4158\/EP14498.OR_bb0105","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1464-5491.2006.01881.x","volume":"23","author":"Gerstein","year":"2006","journal-title":"Diabet Med"},{"key":"10.4158\/EP14498.OR_bb0110","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s00125-005-0132-0","article-title":"Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study","volume":"49","author":"Yki-J\u00e4rvinen","year":"2006","journal-title":"Diabetologia"},{"key":"10.4158\/EP14498.OR_bb0115","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S0140-6736(08)60485-7","article-title":"Once-daily basal insulin glargine versus thricedaily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial","volume":"371","author":"Bretzel","year":"2008","journal-title":"Lancet"},{"key":"10.4158\/EP14498.OR_bb0120","doi-asserted-by":"crossref","first-page":"103","DOI":"10.7326\/0003-4819-154-2-201101180-00300","article-title":"Use of twicedaily exenatide in basal insulin-treated patients with type 2 diabetes: a randomized, controlled trial","volume":"154","author":"Buse","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.4158\/EP14498.OR_bb0125","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1463-1326.2012.01618.x","article-title":"Randomized, double-blind, placebo-controlled trial of the once-daily GLP-1 receptor agonist lixisenatide in Asian patients with type 2 diabetes insufficiently controlled on basal insulin with or without a sulfonylurea (GetGoal-L-Asia)","volume":"14","author":"Seino","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"10.4158\/EP14498.OR_bb0130","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.2337\/dc12-2454","article-title":"Adding once-daily lixisenatide for type 2 diabetes inadequately controlled by established basal insulin: a 24-week, randomized, placebo-controlled comparison (GetGoal-L)","volume":"36","author":"Riddle","year":"2013","journal-title":"Diabetes Care"},{"key":"10.4158\/EP14498.OR_bb0135","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.2337\/dc12-2462","article-title":"Adding once-daily lixisenatide for type 2 diabetes inadequately controlled with newly initiated and continuously titrated basal insulin glargine: a 24-week, randomized, placebo-controlled study (GetGoal-Duo 1)","volume":"36","author":"Riddle","year":"2013","journal-title":"Diabetes Care"},{"key":"10.4158\/EP14498.OR_bb0140","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/dom.12262","article-title":"A comparison of adding liraglutide versus a single daily dose of insulin aspart to insulin degludec in subjects with type 2 diabetes (BEGIN: VICTOZA ADD-ON)","volume":"16","author":"Mathieu","year":"2014","journal-title":"Diabetes Obes Metab"},{"key":"10.4158\/EP14498.OR_bb0145","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.2337\/dc14-0001","article-title":"Advancing basal insulin replacement in type 2 diabetes inadequately controlled with insulin glargine plus oral agents: a comparison of adding albiglutide, a weekly GLP-1 receptor agonist, versus thrice-daily prandial insulin lispro","volume":"37","author":"Rosenstock","year":"2014","journal-title":"Diabetes Care"},{"issue":"suppl 1","key":"10.4158\/EP14498.OR_bb0150","first-page":"A246","article-title":"Better glycemic control and less weight gain with once-weekly dulaglutide vs. once-daily insulin glargine, both combined with premeal insulin lispro, in type 2 diabetes patients (AWARD-4)","volume":"63","author":"Jendle","year":"2014","journal-title":"Diabetes"},{"key":"10.4158\/EP14498.OR_bb0155","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1463-1326.2009.01173.x","article-title":"Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes","volume":"12","author":"Vilsb\u00f8ll","year":"2010","journal-title":"Diabetes Obes Metab"},{"key":"10.4158\/EP14498.OR_bb0160","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/j.1463-1326.2008.00967.x","article-title":"Introducing a simplified approach to insulin therapy in type 2 diabetes: a comparison of two single-dose regimens of insulin glulisine plus insulin glargine and oral antidiabetic drugs","volume":"10","author":"Lankisch","year":"2008","journal-title":"Diabetes Obes Metab"},{"key":"10.4158\/EP14498.OR_bb0165","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1463-1326.2009.01165.x","article-title":"Comparison between a basal-bolus and a premixed insulin regimen in individuals with type 2 diabetes-results of the GINGER study","volume":"12","author":"Fritsche","year":"2010","journal-title":"Diabetes Obes Metab"},{"key":"10.4158\/EP14498.OR_bb0170","doi-asserted-by":"crossref","first-page":"727","DOI":"10.4158\/EP10367.OR","article-title":"Comparison of 2 intensification regimens with rapid-acting insulin aspart in type 2 diabetes mellitus inadequately controlled by once-daily insulin detemir and oral antidiabetes drugs: the step-wise randomized study","volume":"17","author":"Meneghini","year":"2011","journal-title":"Endocr Pract"},{"key":"10.4158\/EP14498.OR_bb0175","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1089\/dia.2011.0163","article-title":"Telecare provides comparable efficacy to conventional self-monitored blood glucose in patients with type 2 diabetes titrating one injection of insulin glulisine-the ELEONOR study","volume":"14","author":"Del Prato","year":"2012","journal-title":"Diabetes Technol Ther"},{"key":"10.4158\/EP14498.OR_bb0180","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.diabet.2012.08.010","article-title":"Comparison of stepwise addition of prandial insulin to a basal-bolus regimen when basal insulin is insufficient for glycaemic control in type 2 diabetes: results of the OSIRIS study","volume":"38","author":"Raccah","year":"2012","journal-title":"Diabetes Metab"},{"key":"10.4158\/EP14498.OR_bb0185","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1177\/193229680700100121","article-title":"Benefits and limitations of self-monitoring of blood glucose","volume":"1","author":"Klonoff","year":"2007","journal-title":"J Diabetes Sci Technol"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20393629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20393629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:00:30Z","timestamp":1761516030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20393629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S1530891X20393629"],"URL":"https:\/\/doi.org\/10.4158\/ep14498.or","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fasting Versus Postprandial Hyperglycemia as a Treatment Target to Lower Elevated Hemoglobin A1C","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP14498.OR","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}